Author

Andrew T. McGuire

Primary ORCID profile (0000-0003-1841-6859 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Andrew T. McGuireiD1 paper · University of Washington

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Adian Valdez· 1 shared Alexandra C. WallsiD· 1 shared Alexandra SchäferiD· 1 shared Alexis Hand· 1 shared Amin AddetiaiD· 1 shared Annie Dosey· 1 shared Boston Simmons· 1 shared Cameron StewartiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adian Valdez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV

Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, Nicholas J. Catanzaro, Miranda L. Hubbard, Amin Addetia, Cameron Stewart, Jack T. Brown, Annie Dosey, Adian Valdez, Rashmi Ravichandran, Grace G. Hendricks, Maggie Ahlrichs, Craig Dobbins, Alexis Hand, , Neil P. King

This study develops MERS-CoV vaccines using a protein nanoparticle platform, showing they induce strong neutralizing antibodies and protect mice against MERS-CoV challenge.

bioRxiv · Mar 13, 2024Immunology